2024.06.28
Notice of Board of Directors Appointments
June 28, 2024
J-Pharma Co., Ltd.
J-Pharma Co., Ltd. (Headquarters: Yokohama, Kanagawa; President & CEO: Masuhiro Yoshitake) announces that the following appointments of directors excluding audit and supervisory committee members, have been resolved at the Ordinary General Meeting of Shareholders held on June 28, 2024, and the subsequent Board of Directors meeting.
| Title | Name | |
| Representative Director and President & CEO |
Masuhiro Yoshitake | Re-appointed |
| Director and Chief Financial Officer (CFO) |
Yutaka Fujimoto | Re-appointed |
| External Director | Sadashi Suzuki | Re-appointed |
| External Director | Shinichiro Komoto | Re-appointed |
| External Director | Kazunobu Nishimura | Re-appointed |
| External Director | Reiri Miura | New |
| External Director, Audit and Supervisory Committee Member | Toshiyuki Mori | Continuation |
| External Director, Audit and Supervisory Committee Member | Teruhisa Tajima | Continuation |
| External Director, Audit and Supervisory Committee Member | Kosaku Kawaguchi | Continuation |
Ms. Reiri Miura founded SIIF Impact Capital Inc. in 2022 after gaining global business experience at a general trading company and a major pharmaceutical company.
Ms. Miura currently serves as the Representative Partner of SIIF Impact Capital Inc.
With the appointment of Ms. Reiri Miura as an External Director, the Company will strengthen its corporate governance, accelerate global expansion, and enhance its corporate value.
Inquiries:
J-Pharma Co., Ltd.
Administration Department
Public Relations
Tel: 045-506-1155
Fax: 045-506-1156
info@j-pharma.com
